The Food and Drug Administration gave emergency use authorization on Tuesday to Novavax’s new Covid vaccine designed to target the coronavirus’ dominant XBB sublineage, which is fueling a ...

Novavax Inc.’s new COVID shot got a green light from the U.S. Food and Drug Administration Tuesday. The FDA authorized the vaccine for people 12 years of age and older, giving individuals ...

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced ...

WEDNESDAY, Oct. 4, 2023 (HealthDay News) -- Federal regulators on Tuesday gave the go-ahead to an updated Novavax COVID-19 vaccine, giving Americans a more traditional alternative to two recently ...

The emergency use listing is based on non-clinical data where the vaccine demonstrated immune responses against variants in ...